Driving Biomedical Research and
Diagnosis Since 2001
At immunostep we have been innovating since 2001 to develop comprehensive products that contribute to
improve performance in key areas of clinical research and diagnostic development. Our goal is to improve
research and diagnostic performance by innovating and adapting new technology to collaborate building
meaningful clinical investigation.
Leading-edge research products to
increase the analysis potential.
Leading-edge research products to
increase the analysis potential.
Extensive Research, Development
and Innovation (R&D&I) Programme.
Extensive Research, Development
and Innovation (R&D&I) Programme.
Seeking efficency and offering
alternative to traditional solutions.
Seeking efficency and offering
alternative to traditional solutions.
Succesful technology licensing and
meaningful worldwide collaborations.
Succesful technology licensing and
meaningful worldwide collaborations.
Biotechnology Innovation
We work to achieve customer satisfaction through quality and differentiation of our products. We are
constantly learning and developing as a company and, in the same way, we expect our products and our way
of working to be constantly improving for the benefit of all our collaborators.
UNDER ISO13485:2016 CERTIFIED QUATILY MANAGEMENT SYSTEM.
PRESENT IN 20+ COUNTRIES WORLDWIDE
+500 PUBLICATIONS FEAUTURING IMMUNOSTEP PRODUCTS
UNDER ISO13485:2016 CERTIFIED QUATILY
MANAGEMENT SYSTEM.
PRESENT IN 20+ COUNTRIES WORLDWIDE
+500 PUBLICATIONS FEAUTURING IMMUNOSTEP
PRODUCTS
AT THE LEADING -
EDGE OF TECHNOLOGY
IN RESEARCH AREAS
OF DEVELOPMENT
AT THE LEADING - EDGE OF TECHNOLOGY IN RESEARCH AREAS
OF DEVELOPMENT
P R O D U C T S
ANTIBODIES
Immunostep has long been working to find and develop the best antibodies for Flow Cytometry.
This has allowed us to obtain monoclonal antibodies that afford a better fluorescence intensity than other products available on the market. Moreover, Immunostep subjects all its antibodies to stringent testing such as repeatability, diagnostic sensitivity, analytical sensitivity or linearity, specificity and titre, thereby guaranteeing that all its products are suitable for diagnosis and research.
APOPTOSIS
Apoptosis ("normal" or "programmed" cell death) is the physiological process by
which unwanted or useless cells are eliminated during development and other normal
biological processes.
Flow Cytometry Solution
Immunostep has long been working to find and develop the best antibodies for Flow Cytometry.
This has allowed us to obtain monoclonal antibodies that afford a better fluorescence intensity than other products available on the market. Moreover, Immunostep subjects all its antibodies to stringent testing such as repeatability, diagnostic sensitivity, analytical sensitivity or linearity, specificity and titre, thereby guaranteeing that all its products are suitable for diagnosis and research.